Ensysce Biosciences, Inc. Share Price
NASDAQ: ENSC | Micro CapEnsysce Biosciences, Inc. Stock Performance
Open $0.40 | Prev. Close $0.40 | Circuit Range N/A |
Day Range $0.39 - $0.40 | Year Range $0.23 - $2.65 | Volume 1,743 |
Average Traded $0.40 |
Ensysce Biosciences, Inc. Share Price Today
As of 29 August 2026, Ensysce Biosciences, Inc.'s share price is $0.40. The stock opened at $0.40, compared to its previous close of $0.40. During today's trading session, Ensysce Biosciences, Inc.'s share price traded between $0.39 and $0.40, with an average price of $0.40. Over the past 52 weeks, the stock has recorded a high of $2.65 and a low of $0.23. In terms of performance, Ensysce Biosciences, Inc.'s share price has declined by 36.61% over the last six months and is down 80.67% on a year-on-year basis.
Ensysce Biosciences, Inc. Share Price Chart
Ensysce Biosciences, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.01M | PE Ratio (TTM) -0.10 | Dividend Yield N/A |
EPS (TTM) $-3.98 | Revenue (TTM) $5.07M | Return On Equity (TTM) -316.65% |
Profit Margin -200.85% | Debt to Equity 1.42 | Quarterly Earnings Growth YoY -663.51% |
Ensysce Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
Ensysce Biosciences, Inc. Annual Profit & Loss
All figures in USD
About Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat Opioid use disorder.Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.
Ensysce Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.26 | $0.40 | +54.26% |
Jul 2026 | $0.30 | $0.26 | -10.10% |
Jun 2026 | $0.27 | $0.29 | +1.77% |
May 2026 | $0.35 | $0.28 | -25.59% |
Apr 2026 | $0.57 | $0.38 | -31.09% |
Mar 2026 | $0.54 | $0.55 | -12.00% |
Feb 2026 | $0.69 | $0.63 | -13.91% |
Jan 2026 | $0.90 | $0.73 | -21.34% |
Dec 2025 | $1.79 | $0.92 | -47.85% |
Nov 2025 | $2.14 | $1.77 | -18.06% |
Oct 2025 | $2.41 | $2.16 | -4.42% |
Sep 2025 | $2.10 | $2.26 | +10.24% |
ENSC Share Price FAQs
What is Ensysce Biosciences, Inc. share price today?
What is the 52 week high and 52 week low of Ensysce Biosciences, Inc. stock?
What is ENSC's market capitalisation today?
What is ENSC's net income for the last quarter?
What is the 5 year returns of ENSC?
What is the high & low stock price of ENSC today?
Can I buy ENSC shares in India?